Inhibitor Therapeutics Inc

(OTC:INTI)

By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Inhibitor Therapeutics Inc is a pharmaceutical development company focused on developing and commercializing therapies for patients with cancer and non-cancerous proliferation disorders. The company's main focus is to advance its lead product, SUBA-Itraconazole a patented, oral formulation of the currently marketed, well-understood, anti-fungal drug, Itraconazole, for prostate and lung cancer.

Contact Information

Website: www.inhibitortx.com
Email: info@cbi-biotech.com
Main Phone: +1 813 509-2420
Address: 4830 West Kennedy Boulverad
Address 2: Suite 600
State: FL
City / Town: Tampa
Country: US
Postal Code: 33609

Issuer Information

Exchange: OTCQB
CEO: William X. Guo
Employees: 2
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A